Show your support of CIRI with the 'CIRI Supporter' logo, available for display on your Web site upon joining CIRI.
Join today and help CIRI advance the cause of cleaner, more productive, and healthier indoor environments through scientific research!
Salmonella
There are more than 2300 types of Salmonella.
By Zoutman, Shannon, Mandel
Abstract
Vapor-based fumigant systems for disinfection of health care surfaces and spaces is an evolving technology.
Abstract
Vapor-based fumigant systems for disinfection of health care surfaces and spaces is an evolving technology. A new system (AsepticSure) uses an ozone-based process to create a highly reactive oxidative vapor with broad and high-level antimicrobial properties.
Methods
Ozone gas at 50-500 ppm was combined with 3% hydrogen peroxide vapor in a test chamber and upscaled in rooms measuring 82 m3 and 90 m3 in area. Test organisms included methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, Escherichia coli, Pseudomonas aeruginosa, Clostridium difficile, and Bacillus subtilis spores dried onto steel discs or cotton gauze pads.
Results
The combination of 80-ppm ozone with 1% hydrogen peroxide vapor achieved a very high level of disinfection, with a ≥6 log10 reduction in the bacteria and spores tested on steel discs and MRSA tested on cotton gauze during a 30- to 90-minute exposure. The entire system was scalable such that it achieved the same high level of disinfection in both the 81-m3 and 90-m3 rooms in 60-90 minutes.
Conclusion
The ozone hydrogen peroxide vapor system provides a very high level of disinfection of steel and gauze surfaces against health care-associated bacterial pathogens. The system is an advanced oxidative process providing a rapid and effective means of disinfecting health care surfaces and spaces.
Authors
Dick Zoutman, MD
Michael Shannon, MD, MSc
Arkady Mandel, MD, PhD, DSc
Published online 06 May 2011.
Conflict of interest: Research funded by Medizone International Inc.
PII: S0196-6553(11)00160-X
doi:10.1016/j.ajic.2011.01.012
© 2011 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc All rights reserved.
The Cleaning Industry Research Institute (CIRI) is a 501.c.3 not-for-profit scientific, educational and research organization that applies science to the practice and improvement of cleaning and maintenance.
This abstract/brief is presented under the recognized "fair use" doctrine with respect to article copyright and intellectual property. Readers are encouraged to secure the full article from the originating publication source. Articles also may be obtained through a librarian, an information specialist or inter-library loan. In cases where payment is required under copyright it can be processed through a reference library or the Copyright Clearance Center at www.copyright.com.
CIRI provides no warranty, expressed or implied, and assumes no legal liability for the accuracy, completeness or usefulness of any information disclosed on its site. The views and opinions of authors expressed herein do not necessarily reflect those of CIRI principals, executives, science advisors or affiliates.
Popular Topics: Swine Flu | H1N1 | MRSA | Staph | Norovirus | Flu | E. Coli | C. Difficile | Salmonella | Green Cleaning | Cleaning for Health | Nosocomial Infections | Disinfection | Bacteria | Viruses | Indoor Air Quality | Asthma | Allergies | Allergen | Mold
Comment by Allen Rathey on December 22nd, 2011 at 2:59pm
We have added the following info:
Published online 06 May 2011.
Conflict of interest: Research funded by Medizone International Inc.
PII: S0196-6553(11)00160-X
doi:10.1016/j.ajic.2011.01.012
© 2011 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc All rights reserved.
Comment by Joseph Schulman on December 22nd, 2011 at 2:23pm
At least one of the authors of this piece is on the board of directors for this company. This is a conflict of interest and renders any conclusions reached in this study as suspect and of questionable objectivity.